Test Directory
| Test Code | ||||
| MYGRV | ||||
| Test Name | ||||
| MYASTHENIA GRAVIS PANEL | ||||
| CPT Codes | ||||
| 86041, 86042, 86043, 86255 | ||||
| Included Tests | ||||
|
||||
| Expected Turnaround Time | ||||
| 3 - 7 days | ||||
| Clinical Utility | ||||
|
Myasthenia Gravis is a neurological disorder characterized by a decrease in acetylcholine receptors. Patients exhibit skeletal muscle weakness and fatigability. Approximately 80% of patients with Myasthenia Gravis, excluding ocular involvement only, have detectable acetylcholine receptor antibody. There is a strong correlation between the presence of striated muscle antibody and the presence of thymoma. |
||||
| Specimen and Container Info | ||||
|
Specimen Type: Serum
Collection Container: Gold Top, Serum Separator
Desired Specimen Volume: 2 mL
|
||||
| Collection Instructions | ||||
|
||||
| Processing and Submission Instructions | ||||
|
||||
| Transport Instructions | ||||
|
Transport to the laboratory refrigerated. |
||||
| Stability Requirements | ||||
|
||||
| Causes for Rejection | ||||
|
||||
| Methodology | ||||
| See Individual Test Listing | ||||
| Reference Intervals | ||||
|
See patient report. |
||||
| Alternate Names | ||||
|
Myasthenia Gravis Panel 3 |
||||
| Reference Lab | ||||
| Quest Diagnostics Nichols Institute | ||||
| Testing Schedule | ||||
| Routine, 2 times per week | ||||
| Reflex Tests | ||||
| ABTSM | ||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.